SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000939798-20-000007
Filing Date
2020-06-04
Accepted
2020-06-04 17:15:28
Documents
1
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3249
  Complete submission text file 0000939798-20-000007.txt   4923
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 475 INDUSTRIAL BLVD WEST CHICAGO IL 60106
Business Address
Cataldo Tony (Reporting) CIK: 0001450565 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-08092 | Film No.: 20943709